The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and activity of topical 4% doxycycline foam (FDX104) in epidermal growth factor receptor inhibitor (EGFRI) induced skin toxicity.
 
Einat Shacham Shmueli
No Relationships to Disclose
 
Ravit Geva
No Relationships to Disclose
 
Nirit Yarom
No Relationships to Disclose
 
Ayala Hubert
No Relationships to Disclose
 
Rita Keynan
Employment - Foamix
Stock and Other Ownership Interests - Foamix
Patents, Royalties, Other Intellectual Property - Foamix
 
Tal Hetzroni Kedem
Employment - Foamix
Stock and Other Ownership Interests - Foamix
 
Meir Eini
Employment - Foamix
Leadership - Foamix
Stock and Other Ownership Interests - Foamix
Patents, Royalties, Other Intellectual Property - Foamix
 
Dov Tamarkin
Employment - Foamix
Leadership - Foamix
Stock and Other Ownership Interests - Foamix
Patents, Royalties, Other Intellectual Property - Foamix
 
Mitchell Shirvan
Employment - Foamix
Leadership - Foamix
Stock and Other Ownership Interests - Foamix
Patents, Royalties, Other Intellectual Property - Foamix
Travel, Accommodations, Expenses - Foamix